Dr. Mercola isn't one I follow intensely, yet he gets far too much right to ignore. My preference for other sources is probably mostly that I have to wade through far less commercial advertising, or none at all, so you're forewarned.
At any rate, this article about WebMD's 12 top cancer advances for 2008 caught my eye. Wanna guess?
- Erbitux for Lung Cancer
- Gemzar for Pancreatic Cancer
- Treanda for Chronic Lymphocytic Leukemia (CLL)
- Avastin for Metastatic Breast Cancer
- Long-Term Hormone Therapy for Breast Cancer
- Zometa for Breast Cancer
- Pegylated Interferon for Melanoma
- Targeted Erbitux for Colon Cancer
- The Pill Cuts Ovarian-Cancer Risk
- HPV Vaccine May Cut Oral Cancers
- Oncologist Shortage Looms
- Caring for Childhood Cancer Survivors
Two of these are not like the others didn't escape Dr. Mercola's notice.
Is it any wonder that 10 of the 12 “major cancer advances” named by the American Society for Clinical Oncology (ASCO) involve drugs of some sort? Not at all. Most oncologists are completely intertwined with the conventional route of cancer treatment, which almost always involves using powerful drugs, radiation or surgery, and as I mentioned above, WebMD funding is primarily from the drug companies.
Note: not a single mention of vitamin D, yet if you were to create a Google alert for it, you'd get inundated with news articles worldwide each day, as I do. Of course, you can fully supplement vitamin D for under $10 per month per person. No money in that for the pharmaceutical companies, nor, by extension, WebMD.
In the article linked, Dr. Mercola lists his own best cancer advances for 2008.